TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
18/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseTNXP / S&P -7.20% / 15.20% |
WinTNXP / S&P 196.02% / 15.00% |
LoseTNXP / S&P -105.04% / 50.40% |
| 2026-Q11/3 |
LoseTNXP / S&P -11.97% / -4.33% |
WinTNXP / S&P 74.84% / 11.30% |
LoseTNXP / S&P -99.12% / 27.70% |
| 2025-Q41/3 |
LoseTNXP / S&P -35.35% / 2.65% |
WinTNXP / S&P 29.85% / 9.00% |
LoseTNXP / S&P -99.34% / 13.40% |
| 2025-Q30/3 |
LoseTNXP / S&P -32.85% / 8.12% |
LoseTNXP / S&P -8.79% / 4.61% |
LoseTNXP / S&P -101.64% / 13.45% |
| 2025-Q21/3 |
WinTNXP / S&P 101.23% / 10.94% |
LoseTNXP / S&P -21.09% / 4.83% |
LoseTNXP / S&P -101.52% / 10.63% |
| 2025-Q10/3 |
LoseTNXP / S&P -45.82% / -4.27% |
LoseTNXP / S&P TNXP unavailable / 4.98% |
LoseTNXP / S&P -89.10% / 10.57% |
| 2024-Q41/3 |
WinTNXP / S&P 120.00% / 2.41% |
LoseTNXP / S&P TNXP unavailable / 5.25% |
LoseTNXP / S&P -85.07% / 6.15% |
| 2024-Q31/3 |
LoseTNXP / S&P -78.57% / 5.89% |
LoseTNXP / S&P TNXP unavailable / 5.89% |
WinTNXP / S&P 18338.95% / 6.11% |
| 2024-Q21/3 |
LoseTNXP / S&P -88.49% / 4.28% |
LoseTNXP / S&P TNXP unavailable / 5.38% |
WinTNXP / S&P 29278.73% / 5.12% |
| 2024-Q11/3 |
LoseTNXP / S&P -52.50% / 10.56% |
LoseTNXP / S&P TNXP unavailable / 5.71% |
WinTNXP / S&P 91911.86% / 5.59% |
| 2023-Q41/3 |
LoseTNXP / S&P -27.27% / 11.69% |
LoseTNXP / S&P TNXP unavailable / 6.81% |
WinTNXP / S&P 98209.99% / 7.78% |
| 2023-Q31/3 |
LoseTNXP / S&P -65.19% / -3.27% |
LoseTNXP / S&P TNXP unavailable / 7.52% |
WinTNXP / S&P 494.09% / -5.03% |
| 2023-Q21/3 |
LoseTNXP / S&P -57.15% / 8.74% |
LoseTNXP / S&P TNXP unavailable / 9.50% |
WinTNXP / S&P 349.42% / -8.57% |
| 2023-Q12/3 |
WinTNXP / S&P 51.28% / 7.50% |
LoseTNXP / S&P TNXP unavailable / 10.77% |
WinTNXP / S&P 119.10% / -15.69% |
| 2022-Q41/3 |
LoseTNXP / S&P -26.42% / 7.56% |
LoseTNXP / S&P TNXP unavailable / 11.88% |
WinTNXP / S&P 148.67% / -17.99% |
| 2022-Q30/3 |
LoseTNXP / S&P -66.46% / -4.88% |
LoseTNXP / S&P TNXP unavailable / 13.47% |
LoseTNXP / S&P TNXP unavailable / -1.41% |
| 2022-Q20/3 |
LoseTNXP / S&P -78.53% / -16.10% |
LoseTNXP / S&P TNXP unavailable / 13.71% |
LoseTNXP / S&P TNXP unavailable / 11.04% |
| 2022-Q10/3 |
LoseTNXP / S&P -36.11% / -4.60% |
LoseTNXP / S&P TNXP unavailable / 15.97% |
LoseTNXP / S&P TNXP unavailable / 42.23% |
| 2021-Q40/3 |
LoseTNXP / S&P -40.00% / 11.03% |
LoseTNXP / S&P TNXP unavailable / 15.00% |
LoseTNXP / S&P TNXP unavailable / 96.40% |
| 2021-Q30/3 |
LoseTNXP / S&P -45.95% / 0.58% |
LoseTNXP / S&P TNXP unavailable / 10.77% |
LoseTNXP / S&P TNXP unavailable / 69.42% |
| 2021-Q20/3 |
LoseTNXP / S&P -13.28% / 8.55% |
LoseTNXP / S&P TNXP unavailable / 6.58% |
LoseTNXP / S&P TNXP unavailable / 51.81% |
| 2021-Q11/3 |
WinTNXP / S&P 88.24% / 6.17% |
LoseTNXP / S&P TNXP unavailable / -1.06% |
LoseTNXP / S&P TNXP unavailable / 7.39% |
| 2020-Q40/3 |
LoseTNXP / S&P -19.05% / 12.15% |
LoseTNXP / S&P TNXP unavailable / -3.72% |
LoseTNXP / S&P TNXP unavailable / -33.42% |
| 2020-Q31/3 |
WinTNXP / S&P 37.70% / 8.93% |
LoseTNXP / S&P TNXP unavailable / -2.04% |
LoseTNXP / S&P TNXP unavailable / -27.10% |
| 2020-Q20/3 |
LoseTNXP / S&P -14.08% / 20.54% |
LoseTNXP / S&P TNXP unavailable / -0.46% |
LoseTNXP / S&P TNXP unavailable / -27.11% |
| 2020-Q10/3 |
LoseTNXP / S&P -39.32% / -19.60% |
LoseTNXP / S&P TNXP unavailable / 3.47% |
LoseTNXP / S&P TNXP unavailable / -14.75% |
| 2019-Q40/3 |
LoseTNXP / S&P -70.75% / 9.07% |
LoseTNXP / S&P TNXP unavailable / 5.36% |
LoseTNXP / S&P TNXP unavailable / 2.99% |
| 2019-Q30/3 |
LoseTNXP / S&P -70.80% / 1.70% |
LoseTNXP / S&P TNXP unavailable / 5.02% |
LoseTNXP / S&P TNXP unavailable / 0.21% |
| 2019-Q20/3 |
LoseTNXP / S&P -43.15% / 4.30% |
LoseTNXP / S&P TNXP unavailable / 6.64% |
LoseTNXP / S&P TNXP unavailable / 8.65% |
| 2019-Q10/3 |
LoseTNXP / S&P 9.55% / 13.65% |
LoseTNXP / S&P TNXP unavailable / 8.12% |
LoseTNXP / S&P TNXP unavailable / 14.29% |
| 2018-Q40/3 |
LoseTNXP / S&P -62.71% / -13.52% |
LoseTNXP / S&P TNXP unavailable / 9.05% |
LoseTNXP / S&P TNXP unavailable / 18.23% |
| 2018-Q30/3 |
LoseTNXP / S&P -86.74% / 7.71% |
LoseTNXP / S&P TNXP unavailable / 10.21% |
LoseTNXP / S&P TNXP unavailable / 19.06% |
| 2018-Q21/3 |
WinTNXP / S&P 48.33% / 3.43% |
LoseTNXP / S&P TNXP unavailable / 9.03% |
LoseTNXP / S&P TNXP unavailable / 14.46% |
| 2018-Q10/3 |
LoseTNXP / S&P -13.04% / -0.76% |
LoseTNXP / S&P TNXP unavailable / 7.68% |
LoseTNXP / S&P TNXP unavailable / 12.46% |
| 2017-Q40/3 |
LoseTNXP / S&P -24.34% / 6.64% |
LoseTNXP / S&P TNXP unavailable / 7.03% |
LoseTNXP / S&P TNXP unavailable / 13.82% |
| 2017-Q31/3 |
WinTNXP / S&P 5.31% / 4.48% |
LoseTNXP / S&P TNXP unavailable / 5.68% |
LoseTNXP / S&P TNXP unavailable / 17.57% |
| 2017-Q20/3 |
LoseTNXP / S&P -7.28% / 3.09% |
LoseTNXP / S&P TNXP unavailable / 4.83% |
LoseTNXP / S&P TNXP unavailable / 17.74% |
| 2017-Q10/3 |
LoseTNXP / S&P -0.64% / 6.07% |
LoseTNXP / S&P TNXP unavailable / 3.67% |
LoseTNXP / S&P TNXP unavailable / 13.32% |
| 2016-Q40/3 |
LoseTNXP / S&P -32.86% / 3.82% |
LoseTNXP / S&P TNXP unavailable / 2.09% |
LoseTNXP / S&P TNXP unavailable / 7.05% |
| 2016-Q30/3 |
LoseTNXP / S&P -64.82% / 3.85% |
LoseTNXP / S&P TNXP unavailable / 0.20% |
LoseTNXP / S&P TNXP unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | TNXP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -54.24% | 20.78% |
| Annualized return | -54.24% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | TNXP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 83.14% |
| Annualized return | -87.62% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | TNXP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -84.32% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |